← Back to Doximity Stock
Doximity (DOCS) News
New York, New York--(Newsfile Corp. - November 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline. So what: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Doximity faces allegations it failed to disclose that it was losing market share to its competitors with more favorable pricing and engagement models.
Lawsuit alleges Doximity, Inc. made misleading statements to investors from August 8, 2024 to May 13, 2026; lead plaintiff motions are due November 16, 2026 LOS ANGELES, Nov. 10, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS) on behalf of investors who acquired the Company's securities from August 8, 2024 to May 13, 2026.
Disclosure under scrutiny: the securities action challenges whether Doximity's public assurances that investors "won't find any banner ads" and that it had no e-newsletter product were adequate, while the Company allegedly relied on those very light-engagement advertising formats. Disclosure under scrutiny: the securities action challenges whether Doximity's public assurances that investors "won't find any banner ads" and that it had no e-newsletter product were adequate, while the Company allegedly relied on those very light-engagement advertising formats.
NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) investors of the November 16, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Doximity Class Action Lawsuit : Do you, or did you, own shares of Doximity, Inc. (NYSE: DOCS)?
LOS ANGELES, Nov. 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in Doximity, Inc. (NYSE: DOCS) that a securities class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Doximity, Inc. common stock between August 8, 2024 and May 13, 2026, inclusive (the 'Class Period'). Find out if you qualify to recover your per-share losses by choosing to join the class action and submit your trade details.
New York, New York--(Newsfile Corp. - November 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the “Class Period”), of the important November 16, 2026 lead plaintiff deadline.